RESUMEN
Mercury is one of the most toxic heavy metal for mammals particularly in inorganic form. In present study, 3,3'-diselenodipropionic acid (DSePA), a well-known pharmacological diselenide was evaluated for its interaction with HgCl2 and ability to prevent HgCl2-induced toxicity in experimental cellular and mice models. UV-visible, stopped flow, Fourier-transform infrared spectroscopy and 1H nuclear magnetic resonance spectroscopy studies confirmed that DSePA sequestered Hg (II) ions with stoichiometry of 1:1 and binding constant of ~104 M-1. X-ray photoelectron spectroscopy and X-ray powder diffraction analysis suggested that diselenide group of DSePA was involved in the complexation with Hg (II) ions. Further, Hg-DSePA complex degraded within 10 days to form excretable HgSe. The binding constant of DSePA and Hg (II) was comparable with that of dihydrolipoic acid, a standard disulfide compound used in heavy metal detoxification. Corroborating these observations, pre-treatment of DSePA (10 µM) significantly prevented the HgCl2 (50 µM)-induced glutathione oxidation (GSH/GSSG), decrease of thioredoxin reductase (TrxR) and glutathione peroxidase (GPx) activities and cell death in Chinese Hamster Ovary (CHO) cells. Similarly, intraperitoneal administration of DSePA at a dosage of 2 mg/kg for 5 consecutive days prior to exposure of HgCl2 (1 mg/kg) significantly suppressed oxidative stress in renal and hepatic tissues of C57BL/6 mice. In conclusion, the protective effect of DSePA against Hg induced oxidative stress is attributed to its ability to rescue the activities of GPx, TrxR and GSH by sequestering Hg (II) ions. DSePA being a relatively safer selenium-compound for in vivo administration can be explored for mercury detoxification.
Asunto(s)
Antioxidantes , Mercurio/toxicidad , Estrés Oxidativo/efectos de los fármacos , Propionatos , Compuestos de Selenio , Animales , Antioxidantes/química , Antioxidantes/farmacología , Células CHO , Cricetulus , Femenino , Ratones , Propionatos/química , Propionatos/farmacocinética , Propionatos/farmacología , Compuestos de Selenio/química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/farmacologíaRESUMEN
Rheumatoid Arthritis is an inflammatory disease primarily involves the inflamed synovium, affecting about 0.5-1 % population worldwide. It is the assumption from many years that oxidative stress is involved in the pathophysiology of inflammatory disorders like RA and many others. The significance of micronutrients in arthritis is linked to their role as a cofactor for the activation of selenoenzymes. Dietary interventions can manage the clinical symptoms of RA like pain, swelling and tenderness of joints and their associated disability along the progression of disease. This review highlights the antioxidant potential of selenium in treatment of RA along with the scientific evidence that Se supplementation can reduce disease progression by managing its clinical symptoms.
Asunto(s)
Antioxidantes/química , Artritis Reumatoide/tratamiento farmacológico , Compuestos de Selenio/química , Animales , Antioxidantes/farmacocinética , Ingestión de Alimentos , Activación Enzimática , Absorción Gastrointestinal , Humanos , Micronutrientes/química , Micronutrientes/farmacología , Nanoestructuras/química , Estrés Oxidativo , Compuestos de Selenio/farmacocinéticaRESUMEN
Extensive data have reported the involvement of oxidative stress in the pathogenesis of neuropsychiatric disorders, prompting the pursuit of antioxidant molecules that could become adjuvant pharmacological agents for the management of oxidative stress-associated disorders. The 3-[(4-chlorophenyl)selanyl]-1-methyl-1H-indole (CMI) has been reported as an antioxidant and immunomodulatory compound that improves depression-like behavior and cognitive impairment in mice. However, the exact effect of CMI on specific brain cells is yet to be studied. In this context, the present study aimed to evaluate the antioxidant activity of CMI in H2O2-induced oxidative stress on human dopaminergic neuroblastoma cells (SH-SY5Y) and to shed some light into its possible mechanism of action. Our results demonstrated that the treatment of SH-SY5Y cells with 4 µM CMI protected them against H2O2 (343 µM)-induced oxidative stress. Specifically, CMI prevented the increased number of reactive oxygen species (ROS)-positive cells induced by H2O2 exposure. Furthermore, CMI treatment increased the levels of reduced glutathione in SH-SY5Y cells. Molecular docking studies demonstrated that CMI might interact with enzymes involved in glutathione metabolism (i.e., glutathione peroxidase and glutathione reductase) and H2O2 scavenging (i.e., catalase). In silico pharmacokinetics analysis predicted that CMI might be well absorbed, metabolized, and excreted, and able to cross the blood-brain barrier. Also, CMI was not considered toxic overall. Taken together, our results suggest that CMI protects dopaminergic neurons from H2O2-induced stress by lowering ROS levels and boosting the glutathione system. These results will facilitate the clinical application of CMI to treat nervous system diseases associated with oxidative stress.
Asunto(s)
Peróxido de Hidrógeno/toxicidad , Indoles/farmacología , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Compuestos de Selenio/farmacología , Dominio Catalítico , Línea Celular Tumoral , Glutatión/metabolismo , Glutatión Transferasa/química , Glutatión Transferasa/metabolismo , Humanos , Indoles/química , Indoles/metabolismo , Indoles/farmacocinética , Simulación del Acoplamiento Molecular , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/metabolismo , Fármacos Neuroprotectores/farmacocinética , Oxidorreductasas/química , Oxidorreductasas/metabolismo , Unión Proteica , Especies Reactivas de Oxígeno/metabolismo , Compuestos de Selenio/química , Compuestos de Selenio/metabolismo , Compuestos de Selenio/farmacocinéticaRESUMEN
BACKGROUND: Extensive research is being carried out globally to design and develop new selenium compounds for various biological applications such as antioxidants, radio-protectors, anti-carcinogenic agents, biocides, etc. In this pursuit, 3,3'-diselenodipropionic acid (DSePA), a synthetic organoselenium compound, has received considerable attention for its biological activities. SCOPE OF REVIEW: This review intends to give a comprehensive account of research on DSePA so as to facilitate further research activities on this organoselenium compound and to realize its full potential in different areas of biological and pharmacological sciences. MAJOR CONCLUSIONS: It is an interesting diselenide structurally related to selenocystine. It shows moderate glutathione peroxidase (GPx)-like activity and is an excellent scavenger of reactive oxygen species (ROS). Exposure to radiation, as envisaged during radiation therapy, has been associated with normal tissue side effects and also with the decrease in selenium levels in the body. In vitro and in vivo evaluation of DSePA has confirmed its ability to reduce radiation induced side effects into normal tissues. Administration of DSePA through intraperitoneal (IP) or oral route to mice in a dose range of 2 to 2.5 mg/kg body weight has shown survival advantage against whole body irradiation and a significant protection to lung tissue against thoracic irradiation. Pharmacokinetic profiling of DSePA suggests its maximum absorption in the lung. GENERAL SIGNIFICANCE: Research work on DSePA reported in fifteen years or so indicates that it is a promising multifunctional organoselenium compound exhibiting many important activities of biological relevance apart from radioprotection.
Asunto(s)
Antioxidantes/farmacología , Propionatos/farmacología , Protectores contra Radiación/farmacología , Compuestos de Selenio/farmacología , Animales , Antioxidantes/síntesis química , Antioxidantes/farmacocinética , Antioxidantes/toxicidad , Humanos , Oxidación-Reducción/efectos de los fármacos , Propionatos/síntesis química , Propionatos/farmacocinética , Propionatos/toxicidad , Protectores contra Radiación/síntesis química , Protectores contra Radiación/farmacocinética , Protectores contra Radiación/toxicidad , Especies Reactivas de Oxígeno/metabolismo , S-Nitrosotioles/metabolismo , Compuestos de Selenio/síntesis química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/toxicidadRESUMEN
The purpose of this study was to investigate the interactions between different selenium (Se) compounds including sodium selenite (SS), selenium-enriched yeast (SY), and nano-selenium (NS) and various essential trace elements involved in the antioxidant systems, and to evaluate the effects on laying performance and egg quality. A total of 288 21-week-old Hyline Sophie hens were allotted to four dietary treatments: (1) basal diet without Se supplementation; (2) basal diet supplemented with 0.3 mg/kg Se of SS; (3) basal diet supplemented with 0.3 mg/kg Se of SY; (4) basal diet supplemented with 0.3 mg/kg Se of NS. Each treatment had eight replicates with nine hens per replicate. The trial lasted for 35 days. Results demonstrated that NS supplementation decreased the egg production (EP) and increased the feed conversion rate (FCR) and eggshell thickness and that SY changed the egg shape index (p < 0.05). Supplementation with three Se compounds significantly increased serum Se concentration and glutathione peroxidase (GSH-Px) activity in all treatment groups, as well as total superoxide dismutase (T-SOD) activity in the SY and NS groups. Yolk iron (Fe) and copper (Cu) concentrations in the NS group were also increased with Se supplementation. While the serum zinc (Zn) concentration decreased in the NS and SY groups, as well as the yolk manganese (Mn) concentration in the SY group. And the total antioxidant capability (T-AOC) of yolk with 3 days of storage in the SY and NS groups, malondialdehyde (MDA) value in the NS group, and the T-SOD activity and MDA value of yolk with 10 days of storage in the SY group also decreased. Thus, the source of Se compounds may influence the balance between Se and other trace elements including Zn, Mn, Fe, and Cu, which is important for proper antioxidant defense in blood and egg yolk of laying hens.
Asunto(s)
Antioxidantes/metabolismo , Pollos/metabolismo , Yema de Huevo/metabolismo , Compuestos de Selenio/farmacología , Oligoelementos/metabolismo , Animales , Proteínas Aviares/metabolismo , Femenino , Glutatión Peroxidasa/metabolismo , Compuestos de Selenio/farmacocinética , Superóxido Dismutasa/metabolismoRESUMEN
Non-toxic and long-term fluorescent probes for tumor imaging are in urgent need for non-invasively obtaining information about tumor genesis and metastasis in vivo. Here, we present a biocompatible near-infrared fluorescent probe for in vivo long-term imaging of tumor by modifying glucose (Glc), which experiences high uptake in cancer cells, on the surface of near-infrared Ag2Se quantum dots (NIR Ag2Se QDs). The fluorescence of glucose-functionalized Ag2Se QDs (Glc-Ag2Se QDs) from the targeted tumor can be observed in vivo for at least 7 days. In addition, this probe could be excreted through kidneys and the renal excretion ability is favorable for in vivo imaging applications. Moreover, Glc-Ag2Se QDs could be used for tumor targeted imaging of not only human breast cancer cells (MCF-7), but also SW1990 pancreatic cancer cells since glucose is highly taken up in almost all kinds of tumors. Glc-Ag2Se QDs could be a promising general tool for in vivo long-term observation of tumor evolution.
Asunto(s)
Colorantes Fluorescentes/química , Glucosa/química , Neoplasias/diagnóstico por imagen , Puntos Cuánticos/química , Compuestos de Selenio/química , Compuestos de Plata/química , Espectroscopía Infrarroja Corta/métodos , Animales , Línea Celular Tumoral , Colorantes Fluorescentes/farmacocinética , Humanos , Masculino , Ratones , Ratones Desnudos , Microscopía Confocal , Neoplasias/patología , Puntos Cuánticos/metabolismo , Eliminación Renal , Compuestos de Selenio/farmacocinética , Plata/sangre , Compuestos de Plata/farmacocinética , Distribución Tisular , Trasplante HeterólogoRESUMEN
Nanoscale copper chalcogenides have been widely used in nanomedicine, however, their pharmacokinetics, degradation, and biological effects of released copper ions are usually overlooked, which are crucial for their future clinical translation. Herein, we report the in vitro and in vivo release of copper ions from polyvinylpyrrolidone (PVP) functionalized ultrasmall copper selenide (Cu2-xSe) theranostic nanoparticles. We synthesized a Cu2+-specific fluorescent probe (NCM), which can quickly and specifically react with copper ions to exhibit very strong near infrared fluorescence. The in vitro study shows that copper ions can be slowly released from Cu2-xSe nanoparticles in aqueous solution with the progress of their oxidation. The release of copper ions from Cu2-xSe nanoparticles in RAW 264.7 murine macrophages is very fast, evidenced by the gradual increase of fluorescence intensity and the diffusion of fluorescence from cytoplasm into nuclei. We also demonstrate the distribution, degradation, and the metabolism of ultrasmall Cu2-xSe nanoparticles by the in vivo fluorescence imaging, the blood routine test, blood biochemistry and histology analysis, and the characterization of copper transport and binding proteins. The results show that ultrasmall Cu2-xSe nanoparticles were mainly eliminated through feces and urine from the body within 72 h after intravenous injection, and the released copper ions did not cause severe toxicity. Our research highlights the great potential of copper chalcogenide nanoparticles in nanomedicine.
Asunto(s)
Cobre , Nanopartículas/química , Compuestos de Selenio , Animales , Cobre/química , Cobre/farmacocinética , Cobre/farmacología , Femenino , Ratones , Ratones Endogámicos BALB C , Células RAW 264.7 , Compuestos de Selenio/química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/farmacología , Nanomedicina TeranósticaRESUMEN
Selenium (Se) compounds have demonstrated anticancer properties in both preclinical and clinical studies, with particular promise in combination therapy where the optimal form and dose of selenium has yet to be established. In a phase I randomised double-blinded study, the safety, tolerability and pharmacokinetic (PK) profiles of sodium selenite (SS), Se-methylselenocysteine (MSC) and seleno-l-methionine (SLM) were compared in patients with chronic lymphocytic leukaemia and a cohort of patients with solid malignancies. Twenty-four patients received 400 µg of elemental Se as either SS, MSC or SLM for 8 weeks. None of the Se compounds were associated with any significant toxicities, and the total plasma Se AUC of SLM was markedly raised in comparison to MSC and SS. DNA damage assessment revealed negligible genotoxicity, and some minor reductions in lymphocyte counts were observed. At the dose level used, all three Se compounds are well-tolerated and non-genotoxic. Further analyses of the pharmacodynamic effects of Se on healthy and malignant peripheral blood mononuclear cells will inform the future evaluation of higher doses of these Se compounds. The study is registered under the Australian and New Zealand Clinical Trials Registry No: ACTRN12613000118707.
Asunto(s)
Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Leucemia Linfocítica Crónica de Células B/metabolismo , Compuestos de Selenio/farmacocinética , Selenocisteína/análogos & derivados , Selenometionina/farmacocinética , Anciano , Anciano de 80 o más Años , Daño del ADN/efectos de los fármacos , Daño del ADN/genética , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Compuestos de Selenio/efectos adversos , Selenocisteína/efectos adversos , Selenocisteína/farmacocinética , Selenometionina/efectos adversosRESUMEN
In this study, we investigated multi-generational effects and generation particle transfer in Caenorhabditis elegans following maternal food exposure to core-shell quantum dots. We found that that the Bag of Worms (BOW) phenotype in aged worms induces changes in quantum dot distribution in the parental body, which is related to the inter-generation transfer of these nanoparticles and to their effects in the offspring. To confirm these results we examined a variety of endpoints, namely, survival, reproduction, aging phenotype, oxidative stress, and intestinal fat metabolism. We show that worms born to parents at different times after exposure show different phenotypic effects as a consequence of quantum dot transfer. This evidence of trans-generational transfer and the effects of nanoparticles highlights the complex multi-generational effects and potential safety hazards that can occur under real environmental conditions.
Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/fisiología , Exposición Dietética/efectos adversos , Exposición Materna/efectos adversos , Nanopartículas/toxicidad , Envejecimiento/efectos de los fármacos , Animales , Compuestos de Cadmio/química , Compuestos de Cadmio/farmacocinética , Compuestos de Cadmio/toxicidad , Caenorhabditis elegans/genética , Efecto de Cohortes , Femenino , Masculino , Estrés Oxidativo/efectos de los fármacos , Fenotipo , Puntos Cuánticos/toxicidad , Reproducción/efectos de los fármacos , Compuestos de Selenio/química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/toxicidad , Compuestos de Zinc/química , Compuestos de Zinc/farmacocinética , Compuestos de Zinc/toxicidadRESUMEN
Nanocapsules (NCS-DOX) with an oily core of selol and a shell of poly(methyl vinyl ether-co-maleic anhydride) covalently conjugated to doxorubicin were developed. These nanocapsules are spherical, with an average hydrodynamic diameter of about 170 nm, and with negative zeta potential. NCS-DOX effectively co-delivered the selol and the doxorubicin into 4T1 cells and changed the intracellular distribution of DOX from the nuclei to the mitochondria. Moreover, a significantly increased cytotoxicity against 4T1 cells was observed, which is suggestive of additive or synergic effect of selol and doxorubicin. In conclusion, PVM/MA nanocapsules are suitable platforms to co-deliver drugs into cancer cells.
Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Doxorrubicina , Neoplasias Mamarias Animales/tratamiento farmacológico , Nanocápsulas , Compuestos de Selenio , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Animales , Línea Celular Tumoral , Núcleo Celular/metabolismo , Núcleo Celular/patología , Doxorrubicina/química , Doxorrubicina/farmacocinética , Doxorrubicina/farmacología , Femenino , Neoplasias Mamarias Animales/metabolismo , Neoplasias Mamarias Animales/patología , Ratones , Mitocondrias/metabolismo , Mitocondrias/patología , Células 3T3 NIH , Nanocápsulas/química , Nanocápsulas/uso terapéutico , Compuestos de Selenio/química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/farmacologíaRESUMEN
We report on the effect of surface charge and the ligand coating composition of CdSe/ZnS core/shell quantum dot (QD) nanoparticles on human keratinocyte toxicity using fluorescent microscopy, flow cytometry, transmission electron microscopy. Two commonly reported positive charged (cysteamine, polyethylenimine) and two negative charged (glutathione, dihydrolipoic acid) ligands were studied. The QDs were fully characterized by UV-vis absorption spectroscopy, fluorescence emission spectroscopy, dynamic light scattering and zeta potential. Differences in surface coatings and charges were evaluated against cellular uptake, ROS generation, cytotoxicity, and mitochondrial targeting. Results show that the negative charged QDs coated with GSH exhibit excellent water solubility, high quantum yield and low cytotoxicity. Ligand composition is more important in ROS generation than surface charge whereas surface charge is an important driver of cytotoxicity. Most importantly we observe the selective accumulation of glutathione coated QDs in vesicles in the mitochondria matrix. This observation suggests a new strategy for developing mitochondria-targeted nanomaterials for drug/gene delivery.
Asunto(s)
Membrana Celular/metabolismo , Mitocondrias/metabolismo , Puntos Cuánticos , Compuestos de Cadmio/química , Compuestos de Cadmio/farmacocinética , Compuestos de Cadmio/toxicidad , Línea Celular Transformada , Supervivencia Celular/efectos de los fármacos , Glutatión , Humanos , Puntos Cuánticos/química , Puntos Cuánticos/metabolismo , Puntos Cuánticos/toxicidad , Compuestos de Selenio/química , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/toxicidad , Solubilidad , Sulfuros/química , Sulfuros/farmacocinética , Sulfuros/toxicidad , Propiedades de Superficie , Compuestos de Zinc/química , Compuestos de Zinc/farmacocinética , Compuestos de Zinc/toxicidadRESUMEN
It has been shown that a rhenium-(I)-diselenoether complex had significant antitumor activity in MDA-MB231 tumor-bearing mice after repeated oral or intraperitoneal administrations for 4 weeks at safe doses of 10 mg/kg/day. It has also been suggested that lower doses could be as effective as this dose. We, thus, tested two doses (5 and 10 mg/kg). The drug was orally administered daily by gavage for 4 weeks and for a further 2 weeks with or without 15 mg/kg paclitaxel treatment (intravenously, once a week). This experiment was performed in MDA-MB 231 tumor-bearing mice, as a model of resistant breast tumor. However, in contrast to previous studies, the mice were pretreated with total body irradiation to increase the tumor growth. These two doses were safe, even in combination with paclitaxel. The expected tumor regression was not observed with the rhenium-(I)-diselenoether complex, and there was even a significant increase of the tumor volume in mice treated with 10 mg/kg versus controls. No synergism was observed with paclitaxel. We comment on the possible negative impact of radiotherapy on the antitumor activity of the drug. Plasma and tumor rhenium and selenium concentrations are also reported.
Asunto(s)
Antineoplásicos/uso terapéutico , Renio/uso terapéutico , Compuestos de Selenio/uso terapéutico , Irradiación Corporal Total , Animales , Antineoplásicos/farmacocinética , Femenino , Humanos , Ratones , Ratones Endogámicos BALB C , Compuestos de Selenio/farmacocinética , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
UNLABELLED: In the marine environment, bacteria from estuarine and coastal sediments are among the first targets of nanoparticle pollution; it is therefore relevant to improve the knowledge of interactions between bacteria and nanoparticles. In this work, the response of the marine bacterium Pseudomonas fluorescens BA3SM1 to CdSe nanocrystals (CdSe NPs) of 3nm (NP3) and 8nm (NP8) in diameter was evaluated through microscopic, physiological, biochemical and proteomic approaches. Transmission electron microscopy images showed that NP3 were able to penetrate the bacteria, while NP8 were highly concentrated around the cells, embedded in large exopolysaccharides. In our experimental conditions, both CdSe NP sizes induced a decrease in respiration during the stationary growth phase, while only NP8 caused growth retardation and a decrease in pyoverdine production. Proteomic analyses highlighted that the strain responded to CdSe NP toxicity by inducing various defence mechanisms such as cell aggregation, extracellular CdSe NP sequestration, effective protection against oxidative stress, modifications of envelope organization and properties, and cadmium export. In addition, BA3SM1 presented a biosorption capacity of 1.6×10(16)NP3/g dry weight and 1.7×10(15)NP8/g dry weight. This strain therefore appears as a promising agent for NP bioremediation processes. Proteomic data are available via ProteomeXchange with identifier PXD004012. BIOLOGICAL SIGNIFICANCE: To the best of our knowledge, this is the first report focussing on the effects of CdSe colloidal nanocrystals (CdSe NPs) on a marine strain of Pseudomonas fluorescens. CdSe NPs are extensively used in the industry of renewable energies and it is regrettably expected that these pollutants will sometime soon appear in the marine environment through surface runoff, urban effluents and rivers. Bacteria living in estuarine and coastal sediments will be among the first targets of these new pollutants. The pseudomonads are frequently found in these ecosystems. They are involved in several biogeochemical cycles and are known for their high resistance to pollutants. Consequently, this study focussing on the effects of CdSe NPs on the marine strain P. fluorescens BA3SM1 is highly relevant for several reasons. First, it aims at improving knowledge about the interactions between bacteria and NPs. This is fundamental to effectively use NPs against pathogenic bacteria. Secondly, in spite of CdSe NP interactions with the bacterial cells, the strain BA3SM1 can develop various strategies to counteract CdSe NP toxicity and ensure its growth. It exhibits interesting properties to sequester CdSe NPs and it retains its ability to form biofilm. The strain therefore appears as a promising agent for NP bioremediation thanks to biofiltration processes. Finally, this study shows that CdSe NPs of 8nm in diameter cause a decrease in the secretion of siderophore pyoverdine, a secondary metabolite playing a key role in microbial ecology since it drives bacterial survival and competitiveness in ecosystems. Bacteria producing effective siderophores survive better in a Fe-deficient environment where they antagonize the growth of other microbes thought iron deprivation. Furthermore, siderophores are also employed as virulence factors in human pathogenic strains such as P. aeruginosa. Consequently, this study highlights that NPs can impact the secondary metabolism of bacteria with environmental and medical implications. In addition, in this work, Data-Dependant Acquisition (DDA) provided state of the art Mass Spectrometry data by Spectral Counting and MS1 Label-Free. The combination of these two well-known proteomic techniques including manual validations strengthened the identification and quantification of regulated proteins. Moreover, numerous correlations between proteomic analyses and other observations (physiological, biochemical, microscopic) consolidated our interpretations.
Asunto(s)
Biodegradación Ambiental , Compuestos de Cadmio/toxicidad , Pseudomonas fluorescens/efectos de los fármacos , Compuestos de Selenio/toxicidad , Contaminantes Químicos del Agua/toxicidad , Compuestos de Cadmio/farmacocinética , Ecosistema , Residuos Industriales , Nanopartículas del Metal/química , Tamaño de la Partícula , Proteómica , Pseudomonas fluorescens/crecimiento & desarrollo , Pseudomonas fluorescens/metabolismo , Compuestos de Selenio/farmacocinéticaRESUMEN
SCOPE: The trace element selenium (Se) is an integral component of our diet. However, its metabolism and toxicity following elevated uptake are not fully understood. Since the either adverse or beneficial health effects strongly depend on the ingested Se species, five low molecular weight species were investigated regarding their toxicological effects, cellular bioavailability and species-specific metabolism in human cells. METHODS AND RESULTS: For the first time, the urinary metabolites methyl-2-acetamido-2-deoxy-1-seleno-ß-D-galactopyranoside (selenosugar 1) and trimethylselenonium ion (TMSe) were toxicologically characterised in comparison to the food relevant species methylselenocysteine (MeSeCys), selenomethionine (SeMet) and selenite in human urothelial, astrocytoma and hepatoma cells. In all cell lines selenosugar 1 and TMSe showed no cytotoxicity. Selenite, MeSeCys and SeMet exerted substantial cytotoxicity, which was strongest in the urothelial cells. There was no correlation between the potencies of the respective toxic effects and the measured cellular Se concentrations. Se speciation indicated that metabolism of the respective species is likely to affect cellular toxicity. CONCLUSION: Despite being taken up, selenosugar 1 and TMSe are non-cytotoxic to urothelial cells, most likely because they are not metabolically activated. The absent cytotoxicity of selenosugar 1 and TMSe up to supra-physiological concentrations, support their importance as metabolites for Se detoxification.
Asunto(s)
Ácido Selenioso/farmacocinética , Compuestos de Selenio/farmacocinética , Selenocisteína/análogos & derivados , Selenometionina/farmacocinética , Disponibilidad Biológica , Línea Celular Tumoral , Células Hep G2 , Humanos , Límite de Detección , Neuroglía/citología , Neuroglía/efectos de los fármacos , Neuroglía/metabolismo , Selenocisteína/farmacocinética , Urotelio/citología , Urotelio/efectos de los fármacos , Urotelio/metabolismoRESUMEN
As a novel fluorescent probe in the second near-infrared window, Ag2Se quantum dots (QDs) exhibit great prospect in in vivo imaging due to their maximal penetration depth and negligible background. However, the in vivo behavior and toxicity of Ag2Se QDs still largely remain unknown, which severely hinders their wide-ranging biomedical applications. Herein, we systematically studied the blood clearance, distribution, transformation, excretion, and toxicity of polyethylene glycol (PEG) coated Ag2Se QDs in mice after intravenous administration with a high dose of 8 µmol/kg body weight. QDs are quickly cleared from the blood with a circulation half-life of 0.4 h. QDs mainly accumulate in liver and spleen and are remarkably transformed into Ag and Se within 1 week. Ag is excreted from the body readily through both feces and urine, whereas Se is excreted hardly. The toxicological evaluations demonstrate that there is no overt acute toxicity of Ag2Se QDs to mice. Moreover, in regard to the in vivo stability problem of Ag2Se QDs, the biotransformation and its related metabolism are intensively discussed, and some promising coating means for Ag2Se QDs to avert transformation are proposed as well. Our work lays a solid foundation for safe applications of Ag2Se QDs in bioimaging in the future.
Asunto(s)
Puntos Cuánticos/metabolismo , Puntos Cuánticos/toxicidad , Compuestos de Selenio/farmacocinética , Compuestos de Selenio/toxicidad , Compuestos de Plata/farmacocinética , Compuestos de Plata/toxicidad , Animales , Colorantes Fluorescentes/química , Colorantes Fluorescentes/farmacocinética , Colorantes Fluorescentes/toxicidad , Rayos Infrarrojos , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Desnudos , Polietilenglicoles/química , Polietilenglicoles/farmacocinética , Polietilenglicoles/toxicidad , Puntos Cuánticos/química , Distribución Aleatoria , Compuestos de Selenio/sangre , Compuestos de Selenio/química , Compuestos de Plata/sangre , Compuestos de Plata/química , Distribución TisularRESUMEN
In the present study, the concentration of trace elements, total mercury (Hg) and selenium (Se) and mercury forms (MeHg, Hginorg and HgSe) in the vulnerable coastal dolphins Pontoporia blainvillei and Sotalia guianensis were appraised and compared, using metallothioneins (MT) and glutathione (GSH) as biomarkers for trace element exposure. The trace element concentrations varied between muscle and liver tissues, with liver of all dolphin specimens showing higher Hg and Se concentrations than those found in muscle. Hg, MeHg and Hginorg molar concentrations showed a clear increase with Se molar concentrations in the liver of both dolphins, and Se concentrations were higher than those of Hg on a molar basis. Se plays a relevant role in the detoxification of MeHg in the hepatic tissue of both dolphins, forming Hg-Se amorphous crystals in liver. In contrast, MT were involved in the detoxification process of Hginorg in liver. GSH levels in P. blainvillei and S. guianensis muscle tissue suggest that these dolphins have different diving capacities. Muscle Hg concentrations were associated to this tripeptide, which protects dolphin cells against Hg stress.
Asunto(s)
Buceo/fisiología , Delfines/metabolismo , Glutatión/metabolismo , Mercurio/análisis , Metalotioneína/metabolismo , Selenio/análisis , Contaminantes Químicos del Agua/análisis , Animales , Biomarcadores/metabolismo , Brasil , Femenino , Inactivación Metabólica , Hígado/metabolismo , Masculino , Mercurio/farmacocinética , Compuestos de Mercurio/análisis , Compuestos de Mercurio/farmacocinética , Compuestos de Metilmercurio/análisis , Compuestos de Metilmercurio/farmacocinética , Músculos/metabolismo , Estrés Oxidativo/efectos de los fármacos , Selenio/farmacocinética , Compuestos de Selenio/análisis , Compuestos de Selenio/farmacocinética , Oligoelementos/análisis , Oligoelementos/farmacocinética , Contaminantes Químicos del Agua/farmacocinéticaRESUMEN
BACKGROUND AND OBJECTIVES: 3,3' Diseleno dipropionic acid (DSePA), a synthetic compound has been shown to have radioprotective activity, especially as a lung radioprotector. In this study, the pharmacokinetics and biodistribution of DSePA in MX-1 tumour bearing SCID mice were evaluated. METHODS: Twenty SCID mice were administered DSePA (50 mg/kg bodyweight) by oral gavage following which four animals each were sacrificed at 15, 30 min, 1, 2 and 4 h. Blood and tissue samples were collected for determination of DSePA concentration by graphite furnace atomic absorption spectrometry (GFAAS) method. The control group (n = 4) was administered sterile water and sacrificed at 4 h. RESULTS: Peak plasma concentration (C max) of 2.7 µg/ml was observed at 15 min which returned to near baseline (baseline = 0.6 µg/ml) at 1 h following drug administration. Biphasic pharmacokinetics characterized by rapid distribution phase and a slower elimination phase were observed. Highest maximal concentration (C max) of the drug was observed in lung (19.2 µg/g at 30 min) followed by intestine (14.64 µg/g at 15 min) and kidney (12.96 µg/g at 15 min). There was negligible uptake in tumor tissue and no uptake in brain. CONCLUSIONS: DSePA has a favorable pharmacokinetic profile which makes it a potentially good candidate for further development as a radioprotective agent.
Asunto(s)
Medicamentos Herbarios Chinos/farmacocinética , Depuradores de Radicales Libres/farmacocinética , Pulmón/metabolismo , Propionatos/farmacocinética , Protectores contra Radiación/farmacocinética , Compuestos de Selenio/farmacocinética , Administración Oral , Animales , Área Bajo la Curva , Barrera Hematoencefálica/metabolismo , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Línea Celular Tumoral , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/metabolismo , Femenino , Depuradores de Radicales Libres/administración & dosificación , Depuradores de Radicales Libres/sangre , Depuradores de Radicales Libres/metabolismo , Semivida , Humanos , Pulmón/patología , Tasa de Depuración Metabólica , Ratones SCID , Especificidad de Órganos , Propionatos/administración & dosificación , Propionatos/sangre , Propionatos/metabolismo , Protectores contra Radiación/administración & dosificación , Protectores contra Radiación/metabolismo , Compuestos de Selenio/administración & dosificación , Compuestos de Selenio/sangre , Compuestos de Selenio/metabolismo , Espectrofotometría Atómica , Distribución Tisular , Carga Tumoral , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Mercury accumulates at high levels in marine mammal tissues. However, its speciation is poorly understood. The main goal of this investigation was to establish the relationships among mercury species and selenium (Se) concentrations in toothed-whale muscles at different mercury levels. The concentrations of total mercury (T-Hg), methylmercury (MeHg), inorganic mercury (I-Hg) and Se were determined in the muscles of four toothed-whale species: bottlenose dolphins (n=31), Risso's dolphins (n=30), striped dolphins (n=29), and short-finned pilot whales (n=30). In each species, the MeHg concentration increased with increasing T-Hg concentration, tending to reach a plateau. In contrast, the proportion of MeHg in T-Hg decreased from 90-100% to 20-40%. The levels of T-Hg and Se showed strong positive correlations. Se/I-Hg molar ratios rapidly decreased with the increase of I-Hg and reached almost 1 in all species. These results suggested that the demethylated MeHg immediately formed Se/I-Hg equimolar complex of mercury selenide (HgSe) in their muscles. In addition, an X-ray absorption fine structure analysis (XAFS) of a bottlenose dolphin muscle confirmed that the dominant chemical form of the Se/I-Hg equimolar complex was HgSe. HgSe was mainly localized in cells near the endomysium using electron probe microanalysis (EPMA). These results suggested that the demethylated MeHg finally deposits within muscle cells of bottlenose dolphin as an inert HgSe.
Asunto(s)
Delfines/metabolismo , Mercurio/farmacocinética , Músculos/metabolismo , Selenio/farmacocinética , Animales , Microanálisis por Sonda Electrónica , Monitoreo del Ambiente , Femenino , Masculino , Compuestos de Mercurio/farmacocinética , Compuestos de Metilmercurio/farmacocinética , Compuestos de Selenio/farmacocinética , Especificidad de la Especie , Contaminantes Químicos del Agua/farmacocinética , Espectroscopía de Absorción de Rayos XRESUMEN
Nanomaterials conjugated with biomacromolecules, including viruses, have great potential for in vivo applications. Therefore, it is important to evaluate the safety of nanoparticle-conjugated macromolecule biomaterials (Nano-mbio). Although a number of studies have assessed the risks of nanoparticles and macromolecule biomaterials in living bodies, only a few of them investigated Nano-mbios. Here we evaluated the in vivo safety profile of a quantum dot-conjugated baculovirus (Bq), a promising new Nano-mbio, in mice. Each animal was injected twice intraperitoneally with 50 µg virus protein labelled with around 3*10(-5)nmol conjugated qds. Control animals were injected with PBS, quantum dots, baculovirus, or a mixture of quantum dots and baculovirus. Blood, tissues and body weight were analysed at a series of time points following both the first and the second injections. It turned out that the appearance and behaviour of the mice injected with Bq were similar to those injected with baculovirus alone. However, combination of baculovirus and quantum dot (conjugated or simply mixed) significantly induced stronger adaptive immune responses, and lead to a faster accumulation and longer existence of Cd in the kidneys. Thus, despite the fact that both quantum dot and baculovirus have been claimed to be safe in vivo, applications of Bq in vivo should be cautious. To our knowledge, this is the first study examining the interaction between a nanoparticle-conjugated virus and a living body from a safety perspective, providing a basis for in vivo application of other Nano-mbios.
Asunto(s)
Baculoviridae/inmunología , Vectores Genéticos/administración & dosificación , Nanopartículas del Metal , Nanoconjugados , Puntos Cuánticos , Reacción de Fase Aguda/etiología , Inmunidad Adaptativa , Animales , Conducta Animal , Biotinilación , Compuestos de Cadmio/análisis , Compuestos de Cadmio/farmacocinética , Citocinas/sangre , Citocinas/metabolismo , Femenino , Vectores Genéticos/efectos adversos , Vectores Genéticos/inmunología , Inyecciones Intraperitoneales , Interferón gamma/biosíntesis , Interferón gamma/genética , Riñón/química , Linfocitos/inmunología , Nanopartículas del Metal/efectos adversos , Ratones , Ratones Endogámicos BALB C , Nanoconjugados/efectos adversos , Nanocáscaras , Puntos Cuánticos/efectos adversos , Compuestos de Selenio/análisis , Compuestos de Selenio/farmacocinética , Bazo/citología , Pérdida de PesoRESUMEN
BACKGROUND: Human prostate cancer (hPCa) is the most commonly diagnosed cancer in elderly men and is the second leading cause of male cancer death. Data from epidemiological, eco-environmental, nutritional prevention and clinical trials suggest that selenium Se(IV) can prevent prostate cancer. Selol, a new organic semisynthetic derivative of Se(IV), is a mixture of selenitetriglycerides. This mixture is non-toxic and non-mutagenic, and after po treatment - 56-times less toxic (in mice) than sodium selenite. It exhibits strong anti-cancer activity in vitro in many cancer cell lines and can overcome the cell resistance to doxorubicin. Selol seems a promising compound for prostate cancer therapy. MATERIALS AND METHODS: The aim of the present study is the evaluation of Selol's influence on intracellular redox state (Eh) of prostatic tumors and the liver in androgen-dependent hPCa-bearing mice, and extracellular redox state in serum of these mice. RESULTS AND CONCLUSIONS: The anticancer activity of Selol involves perturbation of the redox regulation in the androgen dependent hPCa (LNCaP) cells, but not in healthy cells. After Selol treatment, intracellular Eh has increased in tumors from -223 mV to -175 mV, while in serum it has decreased (-82 mV vs -113 mV). It shows significant changes Eh in the extra- and intracellular environment. The difference decreases from 141 mV to 62 mV. The changes suggest that a tumor cell was probably directed toward apoptosis. This is exemplified in a significant decrease in cancer tumor mass by approx. 17% after the three weeks of Selol administration.